Peripheral Neuropathy Trial, Recruiting (NCT06781060)

Peripheral Neuropathy Trial, Recruiting NCT06781060 Sponsor: Azeem Hospital, Multan Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT06781060 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children and teenagers who have been diagnosed with sciatic nerve damage caused by an injection that was given incorrectly into the muscle.
Children between the ages of 3 and 19 years old.
Children whose parents or guardians have given their consent for the child to take part in the study.
Children who are old enough and able to understand what the study involves may also be asked to give their own agreement to participate.

Who may not be able to join:

Children whose condition is severe enough that surgery on the nerve is needed.
Children who have another neurological or muscle-related condition (such as muscular dystrophy or multiple sclerosis) that could affect the study results.
Children who are unable to take part in physical therapy because of another medical condition or significant physical limitation.
Children who have a serious ongoing illness or other significant health condition that could interfere with taking part in the study or affect how results are measured.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Prof Dr Muhammad Zia Ul Haq Professor-Supervisor, PhD, Lincoln University College (LUC), Malaysia

Phone: +923333256772/+60177509748

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06781060

Sponsor: Azeem Hospital, Multan

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: +923333256772/+60177509748

More information: https://clinicaltrials.gov/study/NCT06781060

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children and teenagers who have been diagnosed with sciatic nerve damage caused by an injection that was given incorrectly into the muscle.
Children between the ages of 3 and 19 years old.
Children whose parents or guardians have given their consent for the child to take part in the study.
Children who are old enough and able to understand what the study involves may also be asked to give their own agreement to participate.

Who may not be able to join:

Children whose condition is severe enough that surgery on the nerve is needed.
Children who have another neurological or muscle-related condition (such as muscular dystrophy or multiple sclerosis) that could affect the study results.
Children who are unable to take part in physical therapy because of another medical condition or significant physical limitation.
Children who have a serious ongoing illness or other significant health condition that could interfere with taking part in the study or affect how results are measured.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Azeem Hospital, Multan

Registry

ClinicalTrials.gov

Start date

18 November 2024

Est. completion

1 February 2025

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Nerve Conduction Study (NCS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov